Kalaris Therapeutics
Price & Volume
Stats
See more52W Range | $3.03-$11.88 |
Market Cap | $97.6M |
Shares Short | 393,339 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$1.90 |
News
See moreYahoo Finance • 26 days ago
KLRS: Abbott Cooper PLLC Announces Investigation on Behalf of Kalaris Therapeutics, Inc. (Formerly Allovir, Inc.) Stockholders
Yahoo Finance • last month
Kalaris appoints Liisa Bayko as CFO
Yahoo Finance • last month
Kalaris Therapeutics Reports Positive TH103 Phase 1a SAD Results from Expanded Neovascular AMD Cohorts
About
CEO | Mr. Andrew Oxtoby |
CFO | Ms. Liisa Ann Bayko M.B.A. |
Address | 400 Connell Drive, Berkeley Heights, NJ, United States, 07922 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 20 |